U.S., July 28 -- ClinicalTrials.gov registry received information related to the study (NCT07728669) titled 'Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy' on July 22.

Brief Summary: The goal of this clinical trial is to learn whether the NutriSteppe mobile application can improve blood sugar control and other health measures in adults with type 2 diabetes, obesity, or overweight with related health conditions. All participants are already receiving semaglutide prescribed by their treating physician outside the study.

The main question is:

Does using NutriSteppe for 12 weeks improve glycated hemoglobin (HbA1c), a measure of average blood sugar, compared with routine medical care alone?

Researchers wi...